Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 25, 2023CancersOpen Access

A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

GVGabriela VillanuevaHospital de Clínicas "José de San Martín"MGMartin GuscottResonance (United States)PSPaula SchaiquevichGarrahan Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Villanueva et al. (2023) studied this question.

synapsesocial.com/papers/6a737d51427d94f6ee71afd7https://doi.org/10.3390/cancers15051459
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades2017 · 261 citations
  2. 2Primary CNS Lymphoma2017 · 589 citations
  3. 3Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma2000 · 237 citations
  4. 4Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma2018 · 204 citations
  5. 5Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis2019 · 79 citations